The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers

Diabetologia

Volumn 56, Issue 5, 2013, Pages 1140-1147

  Fagher, K ^a,b   Londahl M ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Foot ulcers; HbA1c; Metabolic control; Mortality; QTc prolongation

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; DIABETIC DIET; DIABETIC FOOT; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIABETIC FOOT; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; LONG QT SYNDROME; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 84876485667     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2860-x     Document Type: Article

References (46)

1. Boulton AJ (2008) The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metabol Res Rev 24(Suppl 1):S3-S6
2. Gershater MA, Londahl M, Nyberg P, et al.(2009) Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52:398-407
3. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580-591
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577-1589
7. American Diabetes Association (2012) Standards of medical care in diabetes-2012. Diabetes Care 35(Suppl 1):S11-S63
8. Inzucchi SE, Bergenstal RM, Buse JB, et al.(2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577-1596
9. Gerstein HC, Miller ME, Byington RP, et al.(2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
10. Dluhy RG, McMahon GT (2008) Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 358:2630-2633
11. Finfer S, Liu B, Chittock DR, et al.(2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367:1108-1118
12. Cryer PE (2011) Death during intensive glycemic therapy of diabetes: mechanisms and implications. Am J Med 124:993-996
13. Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN (2010) Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 33:1529-1535
14. Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM (2010) Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33:1591-1597
15. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R (2009) Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 58:360-366
16. Wright RJ, Frier BM (2008) Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metabol Res Rev 24:353-363
17. Keller-Wood ME, Shinsako J, Dallman MF (1983) Inhibition of the adrenocorticotropin and corticosteroid responses to hypoglycemia after prior stress. Endocrinology 113:491-496
18. Festa A, D'Agostino R Jr, Rautaharju P, Mykkanen L, Haffner SM (2000) Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 86:1117-1122
19. Goldberg RJ, Bengtson J, Chen ZY, Anderson KM, Locati E, Levy D (1991) Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol 67:55-58
20. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH (2004) Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med 164:943-948
21. Macfarlane PW, McLaughlin SC, Devine B, Yang TF (1994) Effects of age, sex, and race on ECG interval measurements. J Electrocardiol 27(Suppl):14-19
22. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D (1994) Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation 90:779-785
23. Levey AS, Coresh J, Greene T, et al.(2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254
24. Marso SP, Hiatt WR (2006) Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 47:921-929
25. Willems JL, Abreu-Lima C, Arnaud P, et al.(1991) The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med 325:1767-1773
26. Macfarlane PW, Devine B, Latif S, McLaughlin S, Shoat DB, Watts MP (1990) Methodology of ECG interpretation in the Glasgow program. Meth Inform Med 29:354-361
27. Bazett H (1920) An analysis of time relations of the electrocardiogram. Heart 7:353-370
28. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J (1993) QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J 70:43-48
29. Currie CJ, Peters JR, Tynan A, et al.(2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481-489
30. Shurraw S, Hemmelgarn B, Lin M, et al.(2011) Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med 171:1920-1927
31. Sturm G, Lamina C, Zitt E, et al.(2011) Association of HbA1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR study and review of the literature. PLoS One 6:e20093
32. Britton KA, Aggarwal V, Chen AY, et al.(2011) No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction. Am Heart J 161(657-663):e651
33. Tanenberg RJ, Newton CA, Drake AJ (2010) Confirmation of hypoglycemia in the 'dead-in-bed' syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 16:244-248
34. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G (2006) Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49:298-305
35. Jacobson AM, Musen G, Ryan CM, et al.(2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852
36. Goldman D (1940) The electrocardiogram in insulin shock. Arch Intern Med 66:93-108
37. Chelliah YR (2000) Ventricular arrhythmias associated with hypoglycaemia. Anaesth Intensive Care 28:698-700
38. Shimada R, Nakashima T, Nunoi K, Kohno Y, Takeshita A, Omae T (1984) Arrhythmia during insulin-induced hypoglycemia in a diabetic patient. Arch Intern Med 144:1068-1069
39. Murphy NP, Ford-Adams ME, Ong KK, et al.(2004) Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia 47:1940-1947
40. Landstedt-Hallin L, Englund A, Adamson U, Lins PE (1999) Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 246:299-307
41. Pappachan JM, Sebastian J, Bino BC, et al.(2008) Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J 84:205-210
42. Veglio M, Chinaglia A, Cavallo-Perin P (2004) QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Investig 27:175-181
43. Pop-Busui R, Evans GW, Gerstein HC, et al.(2010) Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33:1578-1584
44. Moulik PK, Mtonga R, Gill GV (2003) Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26:491-494
45. Cryer PE (2001) Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 281:E1115-E1121
46. Gruden G, Giunti S, Barutta F, et al.(2012) QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care 35:125-127